Active Shortage

MAGNESIUM SULFATE INJECTION USP

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MAGNESIUM SULFATE INJECTION USP in Canada?

Yes. MAGNESIUM SULFATE INJECTION USP 200MG has an active shortage reported to Health Canada (last updated June 15, 2026).

When will MAGNESIUM SULFATE INJECTION USP be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusActive Shortage

Same-ingredient products on file4 products · 0 same form & route

Affected strength200MG

Report last updated2026-06-15

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

MAGNESIUM SULFATE INJECTION, USP

FRESENIUS KABI CANADA LTD

500MG · DIN 02139499

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAGNESIUM SULFATE INJECTION, BP 49.3%

BAXTER CORPORATION

493MG · DIN 02513161

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAGNESIUM SULFATE INJECTION USP

STERIMAX INC

500MG · DIN 02562235

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAGNESIUM SULFATE IN WATER FOR INJECTION

BAXTER CORPORATION

40MG · DIN 02542153

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00392618

Strength

200MG

Dosage Form

LIQUID

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

MAGNESIUM SULFATE

Tier

Unrated

Last Updated

2026-06-15

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929